glp-1-directed nmda receptor antagonism for obesity treatment Caveolae with GLP-1 and Receptors as Crossfire Points the Innovative of Cognitive Dysfunction Associated with Neurodegenerative Diseases Targeting Obesity: GLP-1R, GIPR, GDF8
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20


























